KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsReceivables Refunds
Ratios

BioNTech SE (BNTX) Receivables Refunds (2018 - 2025)

Historic Receivables Refunds for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $99.1 million.

  • BioNTech SE's Receivables Refunds fell 5701.45% to $99.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $99.1 million, marking a year-over-year decrease of 5701.45%. This contributed to the annual value of $53.4 million for FY2024, which is 7227.32% down from last year.
  • According to the latest figures from Q3 2025, BioNTech SE's Receivables Refunds is $99.1 million, which was down 5701.45% from $78.9 million recorded in Q2 2025.
  • BioNTech SE's Receivables Refunds' 5-year high stood at $571.7 million during Q1 2023, with a 5-year trough of $403309.8 in Q3 2022.
  • Moreover, its 5-year median value for Receivables Refunds was $78.9 million (2025), whereas its average is $146.4 million.
  • As far as peak fluctuations go, BioNTech SE's Receivables Refunds surged by 12723731.48% in 2023, and later crashed by 7856.57% in 2025.
  • Over the past 5 years, BioNTech SE's Receivables Refunds (Quarter) stood at $457588.4 in 2021, then fell by 10.82% to $408098.9 in 2022, then soared by 47119.15% to $192.7 million in 2023, then crashed by 72.27% to $53.4 million in 2024, then surged by 85.54% to $99.1 million in 2025.
  • Its Receivables Refunds was $99.1 million in Q3 2025, compared to $78.9 million in Q2 2025 and $63.6 million in Q1 2025.